Table 4.
Median survival times of patients diagnosed with ICC in SEER registry 18 (2000–2017)
| Variable | Median survival time (mon) |
|---|---|
| Sex | |
| Male | 8 |
| Female | 8 |
| Race | |
| White | 8 |
| Black | 7 |
| Other | 8 |
| Therapy | |
| Surgery with chemoradiotherapy | 33 |
| Surgery with chemotherapy | 25 |
| Surgery with radiotherapy | 30 |
| Surgery alone | 32 |
| TNM staging | |
| T1 | 12 |
| T2 | 13 |
| T3 | 8 |
| T4 | 8 |
| TX | 5 |
| Lymph node removal surgery | |
| None | 7 |
| Biopsy or aspiration of regional lymph node | 13 |
| One to three regional lymph nodes removed | 30 |
| Four or more regional lymph nodes removed | 28 |
| Year | |
| 2000–2006 | 12 |
| 2007–2011 | 9 |
| 2012+ | 6 |
| Age group | |
| < 60 years | 9 |
| 60–69 years | 8 |
| ≥ 70 years | 6 |
ICC, intrahepatic cholangiocarcinoma; SEER, Surveillance, Epidemiology, and End Results Program.